H Bakkaloglu
Overview
Explore the profile of H Bakkaloglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
25
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bayraktar A, Dirim A, Bakkaloglu H, Kaan Gok A, Demir E, Ucar A, et al.
Transplant Proc
. 2019 May;
51(4):1187-1189.
PMID: 31101197
Human immunodeficiency virus (HIV) infection has traditionally been considered an absolute contraindication for transplantation because immunosuppression will accelerate the disease progression and increase mortality. New antiretroviral agents have given rise...
2.
Bayraktar A, Bakkaloglu H, Demir E, Turkmen A, Azamat I, Caliskan Y, et al.
Transplant Proc
. 2017 Mar;
49(3):609-612.
PMID: 28340843
Acrodermatitis enteropathica syndrome (AE) is a clinical entity that results in severe zinc deficiency. It can be genetic or acquired. Acquired AE has been reported in patients with chronic liver...
3.
Karadeniz S, Akgul S, Ogret Y, Ciftci H, Bayraktar A, Bakkaloglu H, et al.
Transplant Proc
. 2017 Mar;
49(3):445-447.
PMID: 28340809
Introduction: High rates of panel-reactive antibody (PRA) may decrease the chance of kidney transplantation and may result in long waiting periods before transplantation. The calculated PRA (cPRA) is performed based...
4.
Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates
Akgul S, Ciftci H, Temurhan S, Caliskan Y, Bayraktar A, Tefik T, et al.
Transplant Proc
. 2017 Mar;
49(3):425-429.
PMID: 28340805
Background: Human leukocyte antigen (HLA) allo-immunization is caused by various events such as blood transfusions, pregnancies, or organ transplantations, which can lead to sensitization. In this retrospective study, we evaluated...
5.
Ciftci H, Ayna T, Caliskan Y, Guney I, Bakkaloglu H, Nane I, et al.
Transplant Proc
. 2013 Apr;
45(3):895-900.
PMID: 23622581
Background: Tacrolimus, a calcineurin inhibitör, is prescribed to prevent allograft rejection in renal transplantation. Tacrolimus not only has a narrow therapeutic index, but also shows significant interindividual differences. The absorption...
6.
Bakkaloglu H, Salmaslioglu A, Tunca F, Serin K, Agcaoglu O, Nane I, et al.
Transplant Proc
. 2012 Jul;
44(6):1690-3.
PMID: 22841244
Introduction: Venous thromboemboli and bleeding are the complications that threaten the graft and patient's life in the early postoperative period after cadaveric renal transplantation. For this reason, heparin administration after...
7.
Seyhun Y, Ozdilli K, Oguz F, Karahan G, Onal E, Turkmen A, et al.
Transplant Proc
. 2012 Jul;
44(6):1660-6.
PMID: 22841239
Background: This study was designed to determine whether human leukocyte antigen (HLA) and major histocompatibility complex class I chain-related A (MICA) antibody (Ab) production during the first 6 months posttransplantation...
8.
Karahan G, Seyhun Y, Oguz F, Kekik C, Onal E, Caliskan Y, et al.
Transplant Proc
. 2009 Nov;
41(9):3651-4.
PMID: 19917361
Exposure to human leukocyte antigens (HLA) via blood transfusions, pregnancies, and previous transplantations can result in anti-HLA antibody production. The presence of anti-HLA antibodies in recipient sera before transplantation is...
9.
Ozmen V, Asoglu O, Karanlik H, Cabioglu N, Kecer M, Bakkaloglu H
Acta Chir Belg
. 2007 Apr;
107(1):75-7.
PMID: 17405606
Background: Axillary lymph node metastasis of primary ovarian cancer is rare. Case I: A 74-year-old woman presented with a 2 x 2 cm hard, mobile mass in the right axilla....